Search for: "Does 1-19" Results 301 - 320 of 19,551
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 May 2020, 6:02 am
If the performance plan does not have a 90-day requirement, or if there is an alternative way to award performance bonuses or equity grants, a delay would be more feasible. [read post]
21 May 2012, 3:00 am by Ted Folkman
By this I mean that you can’t serve process via email if (1) the defendant is in a Hague Service Convention state; (2) the defendant’s address is known (such that the Convention applies); and (3) the law of the destination state does not provide for service by email so as to bring Article 19 into play. [read post]
As addressed in Part 1 of this article, the Pennsylvania Department of Health (DOH) issued new orders on November 17, 2020 targeted at mitigating the recent surge of COVID-19 cases within the Commonwealth in recent weeks. [read post]
” Notice 19-10 does not discuss what, if any, impact these guidelines/expectations should or will have on non-competition and non-solicitation agreements. [read post]
12 Jun 2023, 7:01 am by David Aaron
(via Getty Images) The post How Much Prison Time Does Former President Trump Face? [read post]
17 Nov 2014, 7:16 am by CBA Futures
Join Fred Headon and Karen Dyck, both members of the Legal Futures Initiative Steering Committee, in a #CBAFutureschat on Wednesday, November 19 from 12.30 to 1 p.m., to launch DoLawDifferently. [read post]
20 Jul 2017, 10:56 am by Simon Lester
-- Does the existence of NAFTA Chapter 19 have an impact on the decision to file AD/CVD petitions? [read post]
10 Jun 2020, 10:20 am by Lindsay S. Smith
In response to the economic destruction wrought by COVID-19, Senators Faith Winter and Julie Gonzales, and Representative Leslie Herod introduced Senate Bill 211 on June 1, 2020. [read post]
12 Nov 2010, 6:29 pm by Lawrence B. Ebert
The crime scene for death number 1 was a funeral home. [read post]
15 Mar 2019, 9:47 am by Sander van Rijnswou
Novelty (Article 100(a) and Article 54(1) EPC)Document (1) does not provide a direct and unambiguous disclosure of the feature of intramuscular injection and is thus not novelty-destroying for the subject-matter of claim 1.(...)5. [read post]